By Nicole Athéa, gynecologist-endocrinologist and Céline Masson, professor of child and adolescent psychopathology
Summary:
The suicidal risk of trans-identified adolescents is higher than that of other young people, with highly variable assessments depending on the studies and groups studied. This risk is all the greater in that psychopathologies and trauma sequelae, which are extremely numerous in this population, are a known factor in suicidal risk. Some studies attribute the reduction in suicidal risk to the medicalization of these young people, which represents an essential legitimization of treatment; as a result, they are often cited by doctors of the genre. However, the methodology of these studies is often open to criticism: they fall far short of the evidence-based medicine criteria that are imperative for assessing the quality of work in the medical field. A 2015 study by Bauer et al. with a "low quality of evidence" provides little support for the thesis of a reduced risk of suicide after hormonal or hormone-surgical treatment of young transgender people. Yet it is regularly cited and referenced, like many others, also of low quality of evidence, that are multiplying in the transgender clinic.
Yorumlar